Your browser is no longer supported. Please, upgrade your browser.
Settings
DHR [NYSE]
Danaher Corporation
IndexS&P 500 P/E40.34 EPS (ttm)7.76 Insider Own0.20% Shs Outstand715.10M Perf Week-3.40%
Market Cap222.57B Forward P/E30.87 EPS next Y10.14 Insider Trans-48.84% Shs Float634.97M Perf Month0.67%
Income5.64B PEG1.81 EPS next Q2.75 Inst Own81.00% Short Float0.77% Perf Quarter-5.86%
Sales28.07B P/S7.93 EPS this Y49.80% Inst Trans0.07% Short Ratio2.07 Perf Half Y30.26%
Book/sh56.19 P/B5.57 EPS next Y3.13% ROA7.30% Target Price348.08 Perf Year40.12%
Cash/sh3.59 P/C87.21 EPS next 5Y22.30% ROE14.90% 52W Range211.22 - 333.96 Perf YTD40.88%
Dividend0.84 P/FCF35.13 EPS past 5Y14.60% ROI6.60% 52W High-6.29% Beta0.71
Dividend %0.27% Quick Ratio1.10 Sales past 5Y9.10% Gross Margin60.40% 52W Low48.16% ATR8.50
Employees67000 Current Ratio1.50 Sales Q/Q22.90% Oper. Margin24.60% RSI (14)50.67 Volatility3.00% 2.54%
OptionableYes Debt/Eq0.59 EPS Q/Q32.10% Profit Margin20.40% Rel Volume1.26 Prev Close316.06
ShortableYes LT Debt/Eq0.59 EarningsOct 21 BMO Payout9.70% Avg Volume2.37M Price312.94
Recom1.90 SMA200.92% SMA501.61% SMA20013.15% Volume2,975,750 Change-0.99%
Oct-15-21Resumed Cowen Outperform $350
Sep-10-21Reiterated BofA Securities Buy $340 → $360
Aug-05-21Resumed Credit Suisse Outperform $306
Jul-23-21Reiterated Goldman Buy $280 → $320
Jul-16-21Initiated The Benchmark Company Buy $330
Apr-07-21Resumed Robert W. Baird Outperform $249
Mar-03-21Resumed Barclays Overweight $260
Dec-02-20Initiated Goldman Buy $250
Nov-25-20Downgrade RBC Capital Mkts Outperform → Sector Perform $273 → $234
Nov-10-20Initiated KeyBanc Capital Markets Overweight $280
Jun-16-20Upgrade Wolfe Research Peer Perform → Outperform
Apr-02-20Downgrade Wolfe Research Outperform → Peer Perform $154
Mar-26-20Upgrade RBC Capital Mkts Sector Perform → Outperform $151 → $157
Feb-03-20Reiterated Needham Buy $167 → $187
Jan-08-20Initiated Wells Fargo Overweight $170
Jan-07-20Initiated Citigroup Buy $180
Nov-15-19Resumed Stifel Hold
Oct-28-19Reiterated Needham Buy $155 → $152
Oct-14-19Resumed Credit Suisse Outperform $151
Jul-19-19Reiterated Needham Buy $142 → $155
Dec-03-21 05:50PM  
Dec-01-21 09:15PM  
Nov-30-21 01:50PM  
10:00AM  
Nov-29-21 07:56AM  
07:00AM  
Nov-23-21 04:15PM  
08:47AM  
Nov-18-21 03:24PM  
07:00AM  
Nov-10-21 04:01PM  
Nov-05-21 10:00AM  
09:53AM  
Oct-31-21 02:21PM  
Oct-29-21 10:14AM  
Oct-26-21 02:48PM  
10:43AM  
Oct-22-21 01:16PM  
10:09AM  
09:31AM  
Oct-21-21 12:45PM  
11:30AM  
07:25AM  
06:00AM  
Oct-14-21 03:01PM  
06:20AM  
Oct-13-21 09:40AM  
Oct-12-21 04:30PM  
Oct-11-21 03:05PM  
Oct-07-21 12:10PM  
10:04AM  
07:33AM  
Oct-06-21 10:13AM  
Oct-05-21 12:45PM  
12:04PM  
08:47AM  
05:00AM  
Oct-01-21 01:25PM  
06:00AM  
Sep-30-21 06:40AM  
Sep-29-21 10:25AM  
10:00AM  
Sep-28-21 06:00AM  
Sep-27-21 10:48AM  
Sep-24-21 08:52AM  
Sep-23-21 08:50AM  
06:41AM  
Sep-22-21 06:20AM  
Sep-21-21 10:19PM  
04:15PM  
12:57PM  
Sep-16-21 10:32AM  
06:10AM  
Sep-15-21 08:30AM  
Sep-14-21 04:15PM  
Sep-13-21 06:57AM  
Sep-09-21 12:37PM  
Sep-08-21 09:00AM  
Sep-06-21 08:30AM  
Sep-03-21 05:50PM  
09:38AM  
Sep-01-21 11:00AM  
11:00AM  
Aug-30-21 02:05PM  
Aug-27-21 11:08AM  
Aug-26-21 09:10AM  
Aug-25-21 04:30PM  
Aug-24-21 08:30AM  
Aug-22-21 09:00AM  
Aug-20-21 08:30AM  
08:00AM  
Aug-17-21 10:18AM  
Aug-13-21 02:23PM  
Aug-09-21 12:28PM  
10:13AM  
Aug-04-21 10:49AM  
Jul-30-21 11:42AM  
Jul-29-21 12:00PM  
11:13AM  
Jul-28-21 10:10AM  
09:00AM  
08:30AM  
08:13AM  
Jul-27-21 09:18AM  
02:05AM  
Jul-26-21 02:53PM  
08:30AM  
Jul-22-21 02:54PM  
11:30AM  
10:05AM  
07:15AM  
06:00AM  
Jul-20-21 06:13PM  
11:40AM  
09:43AM  
Jul-19-21 08:41AM  
Jul-17-21 05:09AM  
Jul-15-21 03:01PM  
Jul-12-21 08:30AM  
Jul-09-21 12:10PM  
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Raskas DanielSVP - Corporate DevelopmentNov 30Option Exercise46.1312,294567,12234,538Dec 01 05:02 PM
Raskas DanielSVP - Corporate DevelopmentNov 30Sale326.0012,2944,007,84422,244Dec 01 05:02 PM
Lalor Angela SSVP, Human ResourcesNov 29Option Exercise65.8337,5132,469,48168,450Nov 30 05:10 PM
Zerhouni Elias A.DirectorNov 29Sale328.423,4091,119,59425,139Nov 30 05:13 PM
Lalor Angela SSVP, Human ResourcesNov 29Sale327.0037,51312,266,75130,937Nov 30 05:10 PM
Raskas DanielSVP - Corporate DevelopmentNov 26Option Exercise46.1312,300567,39934,850Nov 30 05:01 PM
McGrew MatthewEVP & Chief Financial OfficerNov 26Sale325.502,589842,7206,811Nov 30 05:06 PM
Raskas DanielSVP - Corporate DevelopmentNov 26Sale325.3312,3004,001,52222,550Nov 30 05:01 PM
HEFNER LINDA PDirectorNov 18Option Exercise43.928,038353,02752,024Nov 19 05:01 PM
HEFNER LINDA PDirectorNov 18Sale308.854,5481,404,62747,476Nov 19 05:01 PM
HEFNER LINDA PDirectorNov 11Sale303.722,185663,62843,986Nov 12 07:43 AM
Weidemanis JoakimExecutive Vice PresidentNov 10Sale297.555,0001,487,75065,720Nov 12 07:40 AM
RALES MITCHELL PChairman of Exec. CommitteeNov 04Sale305.99194,25759,440,6990Nov 04 06:42 PM
RALES MITCHELL PChairman of Exec. CommitteeNov 04Sale305.85343,862105,169,3731,181,366Nov 04 06:42 PM
RALES MITCHELL PChairman of Exec. CommitteeNov 03Sale307.35343,861105,686,7601,525,228Nov 04 06:42 PM
RALES MITCHELL PChairman of Exec. CommitteeNov 02Sale312.94343,861107,609,0731,869,089Nov 04 06:42 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerAug 13Option Exercise57.905,000289,50021,155Aug 17 05:22 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerAug 13Sale313.405,0001,567,00116,155Aug 17 05:22 PM
Weidemanis JoakimExecutive Vice PresidentJul 30Sale298.936,7002,002,81870,720Aug 02 05:03 PM
McGrew MatthewEVP & Chief Financial OfficerJul 28Option Exercise46.1312,310567,86016,236Jul 29 05:02 PM
Ellis Brian WSVP and General CounselJul 28Option Exercise65.9512,000791,40033,334Jul 29 05:07 PM
McGrew MatthewEVP & Chief Financial OfficerJul 28Sale293.4012,3103,611,7829,400Jul 29 05:02 PM
Ellis Brian WSVP and General CounselJul 28Sale291.0012,0003,492,00021,334Jul 29 05:07 PM
Weidemanis JoakimExecutive Vice PresidentJul 27Option Exercise40.459,467382,94086,887Jul 28 05:04 PM
Weidemanis JoakimExecutive Vice PresidentJul 27Sale289.4516,4674,766,43577,420Jul 28 05:04 PM
HEFNER LINDA PDirectorJul 26Option Exercise38.124,350165,82246,430Jul 28 05:03 PM
List TeriDirectorMay 27Option Exercise38.644,548175,73520,862May 28 04:46 PM
List TeriDirectorMay 27Sale255.104,5481,160,19516,314May 28 04:46 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerMay 21Sale254.756,0061,530,02816,155May 24 05:10 PM
LOHR WALTER GDirectorMay 07Option Exercise38.124,350165,82215,728May 10 05:16 PM
LOHR WALTER GDirectorMay 07Sale259.324,3501,128,04211,378May 10 05:16 PM
Weidemanis JoakimExecutive Vice PresidentApr 27Sale258.7617,1694,442,63384,420Apr 28 05:13 PM
Ellis Brian WSVP & General CounselApr 23Option Exercise65.9510,350682,58231,684Apr 27 05:33 PM
Lalor Angela SSVP, Human ResourcesApr 23Sale255.793,092790,90330,937Apr 27 05:36 PM
Ellis Brian WSVP & General CounselApr 23Sale254.9113,2773,384,48821,334Apr 27 05:33 PM
RALES MITCHELL PChairman of Exec. CommitteeFeb 26Buy221.461,800398,6283,156Mar 02 04:30 PM
RALES MITCHELL PChairman of Exec. CommitteeFeb 26Buy221.594,8001,063,6322,409,190Mar 02 04:30 PM
Ellis Brian WSenior Vice President - GCFeb 12Sale244.593,852942,16118,857Feb 16 05:14 PM
Lalor Angela SSVP, Human ResourcesFeb 12Sale244.696,4371,575,10225,148Feb 16 05:15 PM
HEFNER LINDA PDirectorFeb 12Sale245.005,3761,317,12041,527Feb 23 05:10 PM